Clinical Trials Directory

Trials / Conditions / High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

10 registered clinical trials studyying High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingExploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large
NCT06588205
Fondazione Italiana Linfomi - ETS—
RecruitingEpcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients
NCT06287398
Australasian Leukaemia and Lymphoma GroupPhase 2
RecruitingLoncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large
NCT05600686
Joseph TuscanoPhase 2
SuspendedTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag
NCT04799275
National Cancer Institute (NCI)Phase 2 / Phase 3
Active Not RecruitingParsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Ly
NCT04323956
Mayo ClinicPhase 1
Active Not RecruitingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lympho
NCT03984448
National Cancer Institute (NCI)Phase 2 / Phase 3
RecruitingAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomo
NCT03418038
Mayo ClinicPhase 2
RecruitingPersonalized NK Cell Therapy in CBT
NCT02727803
M.D. Anderson Cancer CenterPhase 2
CompletedDose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagno
NCT02199184
M.D. Anderson Cancer CenterPhase 2
UnknownNK Cells in Cord Blood Transplantation
NCT01619761
M.D. Anderson Cancer CenterPhase 1